CN111378633B - 一种高酶活的磷脂酶c突变体 - Google Patents
一种高酶活的磷脂酶c突变体 Download PDFInfo
- Publication number
- CN111378633B CN111378633B CN201811620055.7A CN201811620055A CN111378633B CN 111378633 B CN111378633 B CN 111378633B CN 201811620055 A CN201811620055 A CN 201811620055A CN 111378633 B CN111378633 B CN 111378633B
- Authority
- CN
- China
- Prior art keywords
- oil
- polypeptide
- polynucleotide
- sequence
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000694 effects Effects 0.000 title abstract description 30
- 102000014384 Type C Phospholipases Human genes 0.000 title abstract description 24
- 108010079194 Type C Phospholipases Proteins 0.000 title abstract description 24
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 95
- 229920001184 polypeptide Polymers 0.000 claims abstract description 89
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 89
- 238000000034 method Methods 0.000 claims abstract description 36
- 108091033319 polynucleotide Proteins 0.000 claims description 33
- 102000040430 polynucleotide Human genes 0.000 claims description 33
- 239000002157 polynucleotide Substances 0.000 claims description 33
- 239000013598 vector Substances 0.000 claims description 33
- 150000007523 nucleic acids Chemical class 0.000 claims description 26
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 23
- 102000039446 nucleic acids Human genes 0.000 claims description 20
- 108020004707 nucleic acids Proteins 0.000 claims description 20
- 239000003921 oil Substances 0.000 claims description 16
- 235000019198 oils Nutrition 0.000 claims description 16
- 239000010779 crude oil Substances 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 230000002255 enzymatic effect Effects 0.000 claims description 7
- 239000013604 expression vector Substances 0.000 claims description 7
- 230000001105 regulatory effect Effects 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 239000000828 canola oil Substances 0.000 claims description 4
- 235000019519 canola oil Nutrition 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 235000004936 Bromus mango Nutrition 0.000 claims description 3
- 235000019487 Hazelnut oil Nutrition 0.000 claims description 3
- 241001072282 Limnanthes Species 0.000 claims description 3
- 240000007228 Mangifera indica Species 0.000 claims description 3
- 235000014826 Mangifera indica Nutrition 0.000 claims description 3
- 235000019483 Peanut oil Nutrition 0.000 claims description 3
- 235000019774 Rice Bran oil Nutrition 0.000 claims description 3
- 235000009184 Spondias indica Nutrition 0.000 claims description 3
- 235000019486 Sunflower oil Nutrition 0.000 claims description 3
- 235000015278 beef Nutrition 0.000 claims description 3
- 239000010495 camellia oil Substances 0.000 claims description 3
- 239000004359 castor oil Substances 0.000 claims description 3
- 235000019438 castor oil Nutrition 0.000 claims description 3
- 239000003240 coconut oil Substances 0.000 claims description 3
- 235000019864 coconut oil Nutrition 0.000 claims description 3
- 230000000295 complement effect Effects 0.000 claims description 3
- 239000010636 coriander oil Substances 0.000 claims description 3
- 235000005687 corn oil Nutrition 0.000 claims description 3
- 239000002285 corn oil Substances 0.000 claims description 3
- 235000012343 cottonseed oil Nutrition 0.000 claims description 3
- 239000002385 cottonseed oil Substances 0.000 claims description 3
- 239000003925 fat Substances 0.000 claims description 3
- 235000019197 fats Nutrition 0.000 claims description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 3
- 239000010468 hazelnut oil Substances 0.000 claims description 3
- 239000010460 hemp oil Substances 0.000 claims description 3
- 239000000944 linseed oil Substances 0.000 claims description 3
- 235000021388 linseed oil Nutrition 0.000 claims description 3
- 239000004006 olive oil Substances 0.000 claims description 3
- 235000008390 olive oil Nutrition 0.000 claims description 3
- 239000003346 palm kernel oil Substances 0.000 claims description 3
- 235000019865 palm kernel oil Nutrition 0.000 claims description 3
- 239000000312 peanut oil Substances 0.000 claims description 3
- 239000008165 rice bran oil Substances 0.000 claims description 3
- 235000005713 safflower oil Nutrition 0.000 claims description 3
- 239000003813 safflower oil Substances 0.000 claims description 3
- 235000012424 soybean oil Nutrition 0.000 claims description 3
- 239000003549 soybean oil Substances 0.000 claims description 3
- 239000002600 sunflower oil Substances 0.000 claims description 3
- 239000003784 tall oil Substances 0.000 claims description 3
- 239000003760 tallow Substances 0.000 claims description 3
- 239000005909 Kieselgur Substances 0.000 claims description 2
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- 241000425037 Toona sinensis Species 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000003463 adsorbent Substances 0.000 claims description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 2
- 239000000919 ceramic Substances 0.000 claims description 2
- 239000013599 cloning vector Substances 0.000 claims description 2
- 239000005373 porous glass Substances 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 abstract description 32
- 230000008569 process Effects 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 50
- 229940024606 amino acid Drugs 0.000 description 32
- 235000001014 amino acid Nutrition 0.000 description 32
- 229940088598 enzyme Drugs 0.000 description 25
- 102000004190 Enzymes Human genes 0.000 description 24
- 108090000790 Enzymes Proteins 0.000 description 24
- 108090000623 proteins and genes Proteins 0.000 description 22
- 108091026890 Coding region Proteins 0.000 description 20
- 239000000523 sample Substances 0.000 description 18
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 16
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000002609 medium Substances 0.000 description 15
- 125000000539 amino acid group Chemical group 0.000 description 14
- 108010076504 Protein Sorting Signals Proteins 0.000 description 13
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 13
- 239000002773 nucleotide Substances 0.000 description 13
- 125000003729 nucleotide group Chemical group 0.000 description 13
- 235000004400 serine Nutrition 0.000 description 13
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 12
- 241000235058 Komagataella pastoris Species 0.000 description 12
- 230000035772 mutation Effects 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 10
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 9
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000000855 fermentation Methods 0.000 description 9
- 230000004151 fermentation Effects 0.000 description 9
- 235000013930 proline Nutrition 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 8
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 8
- 239000004474 valine Substances 0.000 description 8
- 235000014393 valine Nutrition 0.000 description 8
- 244000063299 Bacillus subtilis Species 0.000 description 7
- 235000014469 Bacillus subtilis Nutrition 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 7
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 7
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 7
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 description 7
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 7
- 239000004473 Threonine Substances 0.000 description 7
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 7
- 229960000310 isoleucine Drugs 0.000 description 7
- 238000006467 substitution reaction Methods 0.000 description 7
- 235000008521 threonine Nutrition 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 6
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 6
- 235000004279 alanine Nutrition 0.000 description 6
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 6
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 108010061238 threonyl-glycine Proteins 0.000 description 6
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 5
- 239000004471 Glycine Substances 0.000 description 5
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 5
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 5
- 235000009582 asparagine Nutrition 0.000 description 5
- 229960001230 asparagine Drugs 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 5
- 235000002374 tyrosine Nutrition 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 239000011665 D-biotin Substances 0.000 description 4
- 235000000638 D-biotin Nutrition 0.000 description 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 4
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 4
- 235000011130 ammonium sulphate Nutrition 0.000 description 4
- 235000003704 aspartic acid Nutrition 0.000 description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 4
- 235000004554 glutamine Nutrition 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 229930182817 methionine Natural products 0.000 description 4
- 239000003471 mutagenic agent Substances 0.000 description 4
- 231100000707 mutagenic chemical Toxicity 0.000 description 4
- 230000003505 mutagenic effect Effects 0.000 description 4
- 238000007670 refining Methods 0.000 description 4
- 239000008347 soybean phospholipid Substances 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 3
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 3
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N Ala-Ala-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 3
- LSLIRHLIUDVNBN-CIUDSAMLSA-N Ala-Asp-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN LSLIRHLIUDVNBN-CIUDSAMLSA-N 0.000 description 3
- BEMGNWZECGIJOI-WDSKDSINSA-N Ala-Gly-Glu Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O BEMGNWZECGIJOI-WDSKDSINSA-N 0.000 description 3
- REWSWYIDQIELBE-FXQIFTODSA-N Ala-Val-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O REWSWYIDQIELBE-FXQIFTODSA-N 0.000 description 3
- PEFFAAKJGBZBKL-NAKRPEOUSA-N Arg-Ala-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O PEFFAAKJGBZBKL-NAKRPEOUSA-N 0.000 description 3
- 241000235349 Ascomycota Species 0.000 description 3
- PBSQFBAJKPLRJY-BYULHYEWSA-N Asn-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N PBSQFBAJKPLRJY-BYULHYEWSA-N 0.000 description 3
- SUIJFTJDTJKSRK-IHRRRGAJSA-N Asn-Pro-Tyr Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 SUIJFTJDTJKSRK-IHRRRGAJSA-N 0.000 description 3
- GWTLRDMPMJCNMH-WHFBIAKZSA-N Asp-Asn-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GWTLRDMPMJCNMH-WHFBIAKZSA-N 0.000 description 3
- XACXDSRQIXRMNS-OLHMAJIHSA-N Asp-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N)O XACXDSRQIXRMNS-OLHMAJIHSA-N 0.000 description 3
- RYEWQKQXRJCHIO-SRVKXCTJSA-N Asp-Asn-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 RYEWQKQXRJCHIO-SRVKXCTJSA-N 0.000 description 3
- LDLZOAJRXXBVGF-GMOBBJLQSA-N Asp-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)O)N LDLZOAJRXXBVGF-GMOBBJLQSA-N 0.000 description 3
- PLOKOIJSGCISHE-BYULHYEWSA-N Asp-Val-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O PLOKOIJSGCISHE-BYULHYEWSA-N 0.000 description 3
- 241000228245 Aspergillus niger Species 0.000 description 3
- 240000006439 Aspergillus oryzae Species 0.000 description 3
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 3
- LJEPDHWNQXPXMM-NHCYSSNCSA-N Gln-Arg-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O LJEPDHWNQXPXMM-NHCYSSNCSA-N 0.000 description 3
- JHPFPROFOAJRFN-IHRRRGAJSA-N Gln-Glu-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)N)O JHPFPROFOAJRFN-IHRRRGAJSA-N 0.000 description 3
- YJSCHRBERYWPQL-DCAQKATOSA-N Gln-Pro-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N)N YJSCHRBERYWPQL-DCAQKATOSA-N 0.000 description 3
- QYPKJXSMLMREKF-BPUTZDHNSA-N Glu-Glu-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)N QYPKJXSMLMREKF-BPUTZDHNSA-N 0.000 description 3
- IRXNJYPKBVERCW-DCAQKATOSA-N Glu-Leu-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IRXNJYPKBVERCW-DCAQKATOSA-N 0.000 description 3
- WGYHAAXZWPEBDQ-IFFSRLJSSA-N Glu-Val-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGYHAAXZWPEBDQ-IFFSRLJSSA-N 0.000 description 3
- JBRBACJPBZNFMF-YUMQZZPRSA-N Gly-Ala-Lys Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN JBRBACJPBZNFMF-YUMQZZPRSA-N 0.000 description 3
- GGEJHJIXRBTJPD-BYPYZUCNSA-N Gly-Asn-Gly Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GGEJHJIXRBTJPD-BYPYZUCNSA-N 0.000 description 3
- CLNSYANKYVMZNM-UWVGGRQHSA-N Gly-Lys-Arg Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)N[C@H](C(O)=O)CCCN=C(N)N CLNSYANKYVMZNM-UWVGGRQHSA-N 0.000 description 3
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 3
- RVKIPWVMZANZLI-UHFFFAOYSA-N H-Lys-Trp-OH Natural products C1=CC=C2C(CC(NC(=O)C(N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-UHFFFAOYSA-N 0.000 description 3
- ZYVTXBXHIKGZMD-QSFUFRPTSA-N Ile-Val-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)N ZYVTXBXHIKGZMD-QSFUFRPTSA-N 0.000 description 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
- KKXDHFKZWKLYGB-GUBZILKMSA-N Leu-Asn-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KKXDHFKZWKLYGB-GUBZILKMSA-N 0.000 description 3
- HYIFFZAQXPUEAU-QWRGUYRKSA-N Leu-Gly-Leu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C HYIFFZAQXPUEAU-QWRGUYRKSA-N 0.000 description 3
- SQUFDMCWMFOEBA-KKUMJFAQSA-N Leu-Ser-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 SQUFDMCWMFOEBA-KKUMJFAQSA-N 0.000 description 3
- LFXSPAIBSZSTEM-PMVMPFDFSA-N Leu-Trp-Phe Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)N LFXSPAIBSZSTEM-PMVMPFDFSA-N 0.000 description 3
- PHHYNOUOUWYQRO-XIRDDKMYSA-N Lys-Asp-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)N PHHYNOUOUWYQRO-XIRDDKMYSA-N 0.000 description 3
- DFXQCCBKGUNYGG-GUBZILKMSA-N Lys-Gln-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN DFXQCCBKGUNYGG-GUBZILKMSA-N 0.000 description 3
- GGNOBVSOZPHLCE-GUBZILKMSA-N Lys-Gln-Asp Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O GGNOBVSOZPHLCE-GUBZILKMSA-N 0.000 description 3
- WGLAORUKDGRINI-WDCWCFNPSA-N Lys-Glu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGLAORUKDGRINI-WDCWCFNPSA-N 0.000 description 3
- YFQSSOAGMZGXFT-MEYUZBJRSA-N Lys-Thr-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YFQSSOAGMZGXFT-MEYUZBJRSA-N 0.000 description 3
- RIPJMCFGQHGHNP-RHYQMDGZSA-N Lys-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)N)O RIPJMCFGQHGHNP-RHYQMDGZSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- UZVWDRPUTHXQAM-FXQIFTODSA-N Met-Asp-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O UZVWDRPUTHXQAM-FXQIFTODSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- MYQCCQSMKNCNKY-KKUMJFAQSA-N Phe-His-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CO)C(=O)O)N MYQCCQSMKNCNKY-KKUMJFAQSA-N 0.000 description 3
- RAGOJJCBGXARPO-XVSYOHENSA-N Phe-Thr-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 RAGOJJCBGXARPO-XVSYOHENSA-N 0.000 description 3
- JSGWNFKWZNPDAV-YDHLFZDLSA-N Phe-Val-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 JSGWNFKWZNPDAV-YDHLFZDLSA-N 0.000 description 3
- RGMLUHANLDVMPB-ULQDDVLXSA-N Phe-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N RGMLUHANLDVMPB-ULQDDVLXSA-N 0.000 description 3
- 102000015439 Phospholipases Human genes 0.000 description 3
- 108010064785 Phospholipases Proteins 0.000 description 3
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 3
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 3
- ZPPVJIJMIKTERM-YUMQZZPRSA-N Pro-Gln-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]1CCCN1 ZPPVJIJMIKTERM-YUMQZZPRSA-N 0.000 description 3
- QGLFRQCECIWXFA-RCWTZXSCSA-N Pro-Met-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1)O QGLFRQCECIWXFA-RCWTZXSCSA-N 0.000 description 3
- ZUZINZIJHJFJRN-UBHSHLNASA-N Pro-Phe-Ala Chemical compound C([C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 ZUZINZIJHJFJRN-UBHSHLNASA-N 0.000 description 3
- 241000169446 Promethis Species 0.000 description 3
- FCRMLGJMPXCAHD-FXQIFTODSA-N Ser-Arg-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O FCRMLGJMPXCAHD-FXQIFTODSA-N 0.000 description 3
- MOQDPPUMFSMYOM-KKUMJFAQSA-N Ser-His-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CO)N MOQDPPUMFSMYOM-KKUMJFAQSA-N 0.000 description 3
- IUXGJEIKJBYKOO-SRVKXCTJSA-N Ser-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CO)N IUXGJEIKJBYKOO-SRVKXCTJSA-N 0.000 description 3
- HKHCTNFKZXAMIF-KKUMJFAQSA-N Ser-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC1=CC=C(O)C=C1 HKHCTNFKZXAMIF-KKUMJFAQSA-N 0.000 description 3
- TYVAWPFQYFPSBR-BFHQHQDPSA-N Thr-Ala-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(O)=O TYVAWPFQYFPSBR-BFHQHQDPSA-N 0.000 description 3
- LXWZOMSOUAMOIA-JIOCBJNQSA-N Thr-Asn-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N)O LXWZOMSOUAMOIA-JIOCBJNQSA-N 0.000 description 3
- AHOLTQCAVBSUDP-PPCPHDFISA-N Thr-Ile-Lys Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O AHOLTQCAVBSUDP-PPCPHDFISA-N 0.000 description 3
- WVVOFCVMHAXGLE-LFSVMHDDSA-N Thr-Phe-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(O)=O WVVOFCVMHAXGLE-LFSVMHDDSA-N 0.000 description 3
- BBPCSGKKPJUYRB-UVOCVTCTSA-N Thr-Thr-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O BBPCSGKKPJUYRB-UVOCVTCTSA-N 0.000 description 3
- PELIQFPESHBTMA-WLTAIBSBSA-N Thr-Tyr-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 PELIQFPESHBTMA-WLTAIBSBSA-N 0.000 description 3
- 241000499912 Trichoderma reesei Species 0.000 description 3
- HOJPPPKZWFRTHJ-PJODQICGSA-N Trp-Arg-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N HOJPPPKZWFRTHJ-PJODQICGSA-N 0.000 description 3
- PNHABSVRPFBUJY-UMPQAUOISA-N Trp-Arg-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N)O PNHABSVRPFBUJY-UMPQAUOISA-N 0.000 description 3
- YTYHAYZPOARHAP-HOCLYGCPSA-N Trp-Lys-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)N YTYHAYZPOARHAP-HOCLYGCPSA-N 0.000 description 3
- SUEGAFMNTXXNLR-WFBYXXMGSA-N Trp-Ser-Ala Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O SUEGAFMNTXXNLR-WFBYXXMGSA-N 0.000 description 3
- VCXWRWYFJLXITF-AUTRQRHGSA-N Tyr-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 VCXWRWYFJLXITF-AUTRQRHGSA-N 0.000 description 3
- BEIGSKUPTIFYRZ-SRVKXCTJSA-N Tyr-Asp-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O BEIGSKUPTIFYRZ-SRVKXCTJSA-N 0.000 description 3
- NRFTYDWKWGJLAR-MELADBBJSA-N Tyr-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)O NRFTYDWKWGJLAR-MELADBBJSA-N 0.000 description 3
- LOOCQRRBKZTPKO-AVGNSLFASA-N Tyr-Glu-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 LOOCQRRBKZTPKO-AVGNSLFASA-N 0.000 description 3
- AXWBYOVVDRBOGU-SIUGBPQLSA-N Tyr-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N AXWBYOVVDRBOGU-SIUGBPQLSA-N 0.000 description 3
- DWAMXBFJNZIHMC-KBPBESRZSA-N Tyr-Leu-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O DWAMXBFJNZIHMC-KBPBESRZSA-N 0.000 description 3
- PSALWJCUIAQKFW-ACRUOGEOSA-N Tyr-Phe-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N PSALWJCUIAQKFW-ACRUOGEOSA-N 0.000 description 3
- YMZYSCDRTXEOKD-IHPCNDPISA-N Tyr-Trp-Asn Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N YMZYSCDRTXEOKD-IHPCNDPISA-N 0.000 description 3
- IZFVRRYRMQFVGX-NRPADANISA-N Val-Ala-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N IZFVRRYRMQFVGX-NRPADANISA-N 0.000 description 3
- 108010005233 alanylglutamic acid Proteins 0.000 description 3
- 108010044940 alanylglutamine Proteins 0.000 description 3
- 108010050025 alpha-glutamyltryptophan Proteins 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 108010019832 glycyl-asparaginyl-glycine Proteins 0.000 description 3
- 108010015792 glycyllysine Proteins 0.000 description 3
- 235000014304 histidine Nutrition 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 3
- 108010003700 lysyl aspartic acid Proteins 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 108010074082 phenylalanyl-alanyl-lysine Proteins 0.000 description 3
- 239000011535 reaction buffer Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000010532 solid phase synthesis reaction Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 3
- 108010051110 tyrosyl-lysine Proteins 0.000 description 3
- 108010020532 tyrosyl-proline Proteins 0.000 description 3
- 108010003137 tyrosyltyrosine Proteins 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- JAQNUEWEJWBVAY-WBAXXEDZSA-N Ala-Phe-Phe Chemical compound C([C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 JAQNUEWEJWBVAY-WBAXXEDZSA-N 0.000 description 2
- 108010025188 Alcohol oxidase Proteins 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- MRYDJCIIVRXVGG-QEJZJMRPSA-N Asp-Trp-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O MRYDJCIIVRXVGG-QEJZJMRPSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000194108 Bacillus licheniformis Species 0.000 description 2
- 241000221198 Basidiomycota Species 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 108010008885 Cellulose 1,4-beta-Cellobiosidase Proteins 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 2
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 102000005720 Glutathione transferase Human genes 0.000 description 2
- 108010070675 Glutathione transferase Proteins 0.000 description 2
- MSSJHBAKDDIRMJ-SRVKXCTJSA-N Met-Lys-Gln Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O MSSJHBAKDDIRMJ-SRVKXCTJSA-N 0.000 description 2
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 241000235648 Pichia Species 0.000 description 2
- 241000235403 Rhizomucor miehei Species 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- CICQXRWZNVXFCU-SRVKXCTJSA-N Ser-His-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O CICQXRWZNVXFCU-SRVKXCTJSA-N 0.000 description 2
- 241000187747 Streptomyces Species 0.000 description 2
- 241000187432 Streptomyces coelicolor Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 241000235013 Yarrowia Species 0.000 description 2
- 241000235015 Yarrowia lipolytica Species 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 108010008685 alanyl-glutamyl-aspartic acid Proteins 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- 102000004139 alpha-Amylases Human genes 0.000 description 2
- 229940024171 alpha-amylase Drugs 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- -1 variant Proteins 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- CYNAPIVXKRLDER-LBPRGKRZSA-N (2s)-2-benzamido-3-(4-hydroxy-3-nitrophenyl)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C=1C=CC=CC=1)C1=CC=C(O)C([N+]([O-])=O)=C1 CYNAPIVXKRLDER-LBPRGKRZSA-N 0.000 description 1
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- 241001093951 Ailanthus altissima Species 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 108010037870 Anthranilate Synthase Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- FTSAJSADJCMDHH-CIUDSAMLSA-N Asn-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N FTSAJSADJCMDHH-CIUDSAMLSA-N 0.000 description 1
- VWADICJNCPFKJS-ZLUOBGJFSA-N Asn-Ser-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O VWADICJNCPFKJS-ZLUOBGJFSA-N 0.000 description 1
- CRNKLABLTICXDV-GUBZILKMSA-N Asp-His-Glu Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)O)N CRNKLABLTICXDV-GUBZILKMSA-N 0.000 description 1
- BPTFNDRZKBFMTH-DCAQKATOSA-N Asp-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N BPTFNDRZKBFMTH-DCAQKATOSA-N 0.000 description 1
- 102000004580 Aspartic Acid Proteases Human genes 0.000 description 1
- 108010017640 Aspartic Acid Proteases Proteins 0.000 description 1
- 241001513093 Aspergillus awamori Species 0.000 description 1
- 241000351920 Aspergillus nidulans Species 0.000 description 1
- 101000690713 Aspergillus niger Alpha-glucosidase Proteins 0.000 description 1
- 101000757144 Aspergillus niger Glucoamylase Proteins 0.000 description 1
- 101900318521 Aspergillus oryzae Triosephosphate isomerase Proteins 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 101000775727 Bacillus amyloliquefaciens Alpha-amylase Proteins 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 101000695691 Bacillus licheniformis Beta-lactamase Proteins 0.000 description 1
- 108010029675 Bacillus licheniformis alpha-amylase Proteins 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 101900040182 Bacillus subtilis Levansucrase Proteins 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 241000193764 Brevibacillus brevis Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 241000233652 Chytridiomycota Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000701867 Enterobacteria phage T7 Species 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 101150108358 GLAA gene Proteins 0.000 description 1
- 108010001498 Galectin 1 Proteins 0.000 description 1
- 102100021736 Galectin-1 Human genes 0.000 description 1
- NUMFTVCBONFQIQ-DRZSPHRISA-N Gln-Ala-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O NUMFTVCBONFQIQ-DRZSPHRISA-N 0.000 description 1
- HJIFPJUEOGZWRI-GUBZILKMSA-N Glu-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N HJIFPJUEOGZWRI-GUBZILKMSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- YDIDLLVFCYSXNY-RCOVLWMOSA-N Gly-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN YDIDLLVFCYSXNY-RCOVLWMOSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- VGYOLSOFODKLSP-IHPCNDPISA-N His-Leu-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CN=CN1 VGYOLSOFODKLSP-IHPCNDPISA-N 0.000 description 1
- JUIOPCXACJLRJK-AVGNSLFASA-N His-Lys-Glu Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N JUIOPCXACJLRJK-AVGNSLFASA-N 0.000 description 1
- SYPULFZAGBBIOM-GVXVVHGQSA-N His-Val-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N SYPULFZAGBBIOM-GVXVVHGQSA-N 0.000 description 1
- 241001099157 Komagataella Species 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000233654 Oomycetes Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 241000255969 Pieris brassicae Species 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 101900354623 Saccharomyces cerevisiae Galactokinase Proteins 0.000 description 1
- 101900084120 Saccharomyces cerevisiae Triosephosphate isomerase Proteins 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- PCMZJFMUYWIERL-ZKWXMUAHSA-N Ser-Val-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O PCMZJFMUYWIERL-ZKWXMUAHSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- JLFKWDAZBRYCGX-ZKWXMUAHSA-N Val-Asn-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N JLFKWDAZBRYCGX-ZKWXMUAHSA-N 0.000 description 1
- 241000758405 Zoopagomycotina Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 108010045649 agarase Proteins 0.000 description 1
- 108010066829 alanyl-glutamyl-aspartylprolyine Proteins 0.000 description 1
- 108010051873 alkaline protease Proteins 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000010420 art technique Methods 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 239000012152 bradford reagent Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011098 chromatofocusing Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 108010073128 phosphatidylcholine-specific phospholipase C Proteins 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000010563 solid-state fermentation Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- SPOMEWBVWWDQBC-UHFFFAOYSA-K tripotassium;dihydrogen phosphate;hydrogen phosphate Chemical compound [K+].[K+].[K+].OP(O)([O-])=O.OP([O-])([O-])=O SPOMEWBVWWDQBC-UHFFFAOYSA-K 0.000 description 1
- KMZJRCPGGAQHGC-UHFFFAOYSA-N trisodium boric acid borate Chemical compound [Na+].[Na+].[Na+].OB(O)O.[O-]B([O-])[O-] KMZJRCPGGAQHGC-UHFFFAOYSA-N 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/003—Refining fats or fatty oils by enzymes or microorganisms, living or dead
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/14—Pretreatment of feeding-stuffs with enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/25—Removal of unwanted matter, e.g. deodorisation or detoxification using enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/04—Phosphoric diester hydrolases (3.1.4)
- C12Y301/04003—Phospholipase C (3.1.4.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/84—Pichia
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Polymers & Plastics (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Food Science & Technology (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
本发明提供一种高酶活的磷脂酶C突变体，其序列如SEQ ID NO:7所示的多肽，或在SEQ ID NO:7所述的多肽中经过取代、缺失或添加一个或几个氨基酸，同时保留SEQ ID NO：7所具备的磷脂酶C活性的由其衍生的多肽。本发明的磷脂酶C突变体能提高脱胶效率，增加脱胶过程中甘二酯(DAG)的得率。
Description
技术领域
本发明涉及一种高酶活的磷脂酶C突变体。
背景技术
脱胶是油脂精炼的一个重要步骤，而传统的水化脱胶法经济成本高，物料能耗大，环境污染重，所以近些年，很多努力致力于将酶法脱胶用于油脂精炼中的脱胶环节，并取得了很大的进展。同传统方法相比,酶法脱胶能够提高经济效益，做到节能减排，对生态环境污染少，在环保、经济、质量等方面具有较大的优势。油脂脱胶所用的酶即为磷脂酶，并且同其他脱胶酶相比，磷脂酶C(PLC)表现出更大的优势，比如，增加甘二酯(DAG)的得率，以及减少得油量的损失。
Bacillus cereus的PC-PLC(BC-PC-PLC)是研究较早的一种磷脂酶C。BC-PC-PLC全长为283个氨基酸，其中包含24个氨基酸的信号肽和14个氨基酸的前导肽，成熟肽为245个氨基酸(Johansen et al.1988)。BC-PC-PLC的晶体结构已经被报道，其由多个螺旋结构域组成，催化位点为55位天冬氨酸，并且含有至少三个Zn2+结合位点(Hough et al.1989)。BC-PC-PLC的异源表达研究较少目前只在Bacillus subtilis和pichia pastoris中进行表达(Durban et al.2007；Seo et al.2004)。
在之前的研究中，发明人已经通过将BC-PC-PLC的四个氨基酸即56位，63位，131位和134位天冬酰胺分别突变为组氨酸，天冬氨酸，丝氨酸和天冬氨酸，比酶活相比于野生型大大提高。为了进一步提高该磷脂酶C的比酶活力和脱胶效率，发明人选择了BC-PC-PLC蛋白中第6位，第8位，第10位，第104位，第205位氨基酸进行随机饱和突变，对已有的磷脂酶C突变体进行定向进化，希望能够得到比酶活进一步提高的突变体，从而能够得到更高效的磷脂酶C，提高脱胶效率，增加脱胶过程中甘二酯(DAG)的得率。
发明内容
本发明提供一种分离的多肽，所述多肽选自：
(1)SEQ ID NO:7所示的多肽；和
(2)与SEQ ID NO:7至少80％，优选至少85％，更优选至少90％，更优选至少95％，更优选至少97％，更优选至少98％，更优选至少99％的序列同一性，对应于SEQ ID NO:7第6位、第8位、第10位和第104位中的至少1个位置的氨基酸残基分别相应地与SEQ ID NO:7第6位、第8位、第10位和/或第104位相同，同时保留SEQ ID NO：7所具备的磷脂酶C活性的多肽。
在一个或多个实施方案中，SEQ ID NO:7中，第6位氨基酸残基是脯氨酸或色氨酸；第8位氨基酸残基是丙氨酸、亮氨酸或异亮氨酸；第10位和第104位氨基酸各自独立为丝氨酸或苏氨酸。
在一个或多个实施方案中，所述分离的多肽如SEQ ID NO:4所示。
本发明还提供一种分离的多肽，所述多肽与SEQ ID NO:4所示的氨基酸序列具有至少80％，优选至少85％，更优选至少90％，更优选至少95％，更优选至少97％，更优选至少98％，更优选至少99％的序列同一性，且所述分离多肽在对应于SEQ ID NO:4第6、8、10和104位上的氨基酸残基分别是脯氨酸、缬氨酸、丝氨酸和丝氨酸；优选的，所述多肽获自枯草芽孢杆菌(Bacillus subtilis)。
本发明还提供一种多核苷酸序列，选自：
(1)编码本文任一实施方案所述多肽的多核苷酸序列；和
(2)(1)所述多核苷酸序列的互补序列；和
(3)(1)或(2)所述序列的长15-30个碱基的片段；
优选地，所述多核苷酸序列如SEQ ID NO:3所示。
本发明还提供一种核酸构建体，该核酸构建体包含本文任一实施方案所述的多核苷酸序列和一条或多条与该多核苷酸序列操作性连接的调控序列。
在一个或多个实施方案中，所述核酸构建体为载体。
在一个或多个实施方案中，所述载体为表达载体或克隆载体。
本发明还提供一种遗传工程化的宿主细胞，所述宿主细胞含有本文任一实施方案所述的多核苷酸序列或核酸构建体。
本发明还提供一种组合物，所述组合物含有本文任一实施方案所述的多肽和任选的辅料，优选地，所述辅料为选自活性炭、氧化铝、硅藻土、多孔陶瓷、多孔玻璃的吸附材料。
本发明还提供本文任一实施方案所述的多肽、多核苷酸序列、核酸构建体、宿主细胞或组合物在油脂精炼、磷脂改性、饲料改良剂、食品工业和医药工业中的应用。
本发明还提供一种酶法脱胶方法，所述方法包括使用本文任一实施方案所述的多肽进行脱胶，优选的，所述方法包括将所述多肽与毛油接触的步骤，优选的，所述步骤包括将所述多肽与50-70℃毛油接触。
在一个或多个实施方案中，所述方法包括以下特征中的一项或多项：
(1)以毛油重量计，所述多肽的添加量为10～1000ppm，优选为50～500ppm，更优选为100～300ppm；
(2)所述脱胶包括：在50～60℃下搅拌1～3小时，然后升温至80～90℃保持1～10分钟；和
(3)所述毛油选自：大豆油、葵花籽油、花生油、菜籽油、米糠油、玉米油、橄榄油、棕榈油、棕榈仁油、棕榈软脂、卡诺拉油、蓖麻油、椰子油、芫荽油、棉籽油、榛子油、大麻籽油、亚麻籽油、芒果仁油、白芒花油、牛蹄油、红花油、山茶花油、妥尔油和椿油。
附图说明
图1：突变体的比酶活。
图2：脱胶小试结果。
图3：磷脂酶活力测定标准曲线。
具体实施方式
应理解，在本发明范围中，本发明的上述各技术特征和在下文(如实施例)中具体描述的各技术特征之间都可以互相组合，从而构成优选的技术方案。
本发明提供氨基酸序列如SEQ ID NO：7所示的分离的多肽，或与SEQ ID NO:7至少80％，优选至少85％，更优选至少90％，更优选至少95％，更优选至少97％，更优选至少98％，更优选至少99％的序列同一性，且对应于SEQ ID NO:7第6位、第8位、第10位和第104位中的至少1个位置的氨基酸残基分别相应地与SEQ ID NO:7第6位、第8位、第10位和/或第104位相同，同时保留SEQ ID NO：7所具备的磷脂酶C活性的多肽。
本文中，“分离的”意指在自然界中不存在的一种形式或物质。分离的物质的非限制性例子包括任何非天然存在的物质和至少部分地从与其在自然界中相关联的一种或多种或全部天然存在的组分中除去的任何物质，包括但不限于任何酶、变体、核酸、蛋白质、肽或辅因子。SEQ ID NO:7中，第6位和第8位氨基酸残基(Xaa)可以是具有非极性侧链的氨基酸残基，包括但不限于丙氨酸、缬氨酸、亮氨酸、异亮氨酸、脯氨酸、苯丙氨酸、甲硫氨酸、色氨酸；第10位和第104位氨基酸残基(Xaa)可以是具有不带电荷的极性侧链的氨基酸，包括但不限于甘氨酸、天冬酰胺、谷氨酰胺、丝氨酸、苏氨酸、酪氨酸、半胱氨酸。优选地，SEQ IDNO:7中，第6位氨基酸残基是脯氨酸或色氨酸；第8位氨基酸残基是丙氨酸、亮氨酸或异亮氨酸；第10位和第104位氨基酸各自独立为丝氨酸或苏氨酸。示例性的多肽的氨基酸序列如SEQ ID NO:4所示。
本发明还包括在SEQ ID NO：7的基础上具有一个或多个(通常为1-10个，例如1、2、3、4、5、6、7、8、9或10个)氨基酸突变(缺失、插入和/或取代)、同时保留了SEQ ID NO:4所示氨基酸序列的磷脂酶C活性的多肽。在某些实施方案中，所述氨基酸突变是在SEQ ID NO:7的C末端和/或N末端添加一个或数个(通常为20个以内，较佳地为10个以内，更佳地为8以内)氨基酸的多肽。应理解的是，所述的一个或多个氨基酸突变通常不包括SEQ ID NO:7第6、8、10和104位上的氨基酸(Xaa)全部发生突变的情况。
突变优选为保守性取代。例如，在本领域中，用性能相近或相似的氨基酸进行保守性取代时，通常不会改变蛋白质或多肽的功能。“性能相近或相似的氨基酸”包括例如，具有相似侧链的氨基酸残基的家族，这些家族包括具有碱性侧链的氨基酸(例如赖氨酸、精氨酸、组氨酸)、具有酸性侧链的氨基酸(例如天冬氨酸、谷氨酸)、具有不带电荷的极性侧链的氨基酸(例如甘氨酸、天冬酰胺、谷氨酰胺、丝氨酸、苏氨酸、酪氨酸、半胱氨酸)、具有非极性侧链的氨基酸(例如丙氨酸、缬氨酸、亮氨酸、异亮氨酸、脯氨酸、苯丙氨酸、甲硫氨酸、色氨酸)、具有β-分支侧链的氨基酸(例如苏氨酸、缬氨酸、异亮氨酸)和具有芳香侧链的氨基酸(例如酪氨酸、苯丙氨酸、色氨酸、组氨酸)。因此，在本发明多肽中用来自同一侧链类的另一氨基酸残基替换一个或几个位点，将不会在实质上影响其活性。
在本发明中，术语“随机饱和突变”指将需要突变的位点在PCR引物中以设计为NNK兼并密码子，从而能够覆盖所有20种氨基酸达到饱和突变的效果，又由于选择了多个位点进行突变，其组合方式具有随机性，因此作者将此方法称之为随机饱和突变。
此外，本领域技术人员公知，在基因克隆操作中，常常需要设计合适的酶切位点，这势必在所表达的蛋白末端引入了一个或多个不相干的残基，而这并不影响目的蛋白的活性。又如为了构建融合蛋白、促进重组蛋白的表达、获得自动分泌到宿主细胞外的重组蛋白、或利于重组蛋白的纯化，常常需要将一些氨基酸序列添加至重组蛋白的N末端、C末端或该蛋白内的其它合适区域内，这类氨基酸序列包括但不限于接头肽、信号肽、前导肽、末端延伸、谷胱甘肽S-转移酶(GST)、麦芽糖E结合蛋白、蛋白A、标签(如6His或Flag)、或合适的蛋白水解酶位点等。应理解，这些氨基酸序列的存在不会影响到所得多肽的活性。因此，本发明也包括在本发明多肽的C末端和/或N末端或其蛋白内合适的区域内具有一个或数个利于该多肽表达载体的构建、该多肽的表达和/或纯化的氨基酸的多肽，这些多肽仍具有本文所述的磷脂酶C活性。
因此，在某些实施方案中，本发明包括与SEQ ID NO:7具有至少80％、优选至少85％、更优选至少90％、更优选至少95％、更优选至少96％、更优选至少97％、更优选至少98％、更优选至少99％的序列同一性的氨基酸序列。更进一步地，本发明包括与SEQ ID NO:4具有至少80％、优选至少85％、更优选至少90％、更优选至少95％、更优选至少96％、更优选至少97％、更优选至少98％、更优选至少99％的序列同一性的氨基酸序列；且与SEQ IDNO:4和7具有所述序列同一性的氨基酸序列在对应于SEQ ID NO:4和7第6、8、10和104位上的氨基酸残基未全部发生突变，优选为仍保持为SEQ ID NO:4和7相应位置上的氨基酸残基，例如仍保持为SEQ ID NO:4第6、8、10和104位上的脯氨酸、缬氨酸、丝氨酸和丝氨酸。更优选地，具有所述序列同一性的氨基酸序列获自枯草芽孢杆菌(Bacillus subtilis)。本文中，序列相同性用于描述两个氨基酸序列之间或两个核苷酸序列之间的相关性。可使用本领域周知的方法来计算序列相同性。例如，可使用EMBOSS包(EMBOSS：欧洲分子生物学开放软件套件，赖斯等，2000，遗传学趋势，16:276-277)的尼德尔(Needle)程序中所实施的尼德尔曼-翁施(Needleman-Wunsch)算法(Needleman和Wunsch，1970，分子生物学杂志，48:443-453)来确定两个氨基酸序列之间的序列相同性。或者，可使用NCBI上的BLASTP来计算两条氨基酸序列之间的序列相同性。
根据重组生产方案所用的宿主，本发明的多肽可以是糖基化的，或可以是非糖基化的。
多核苷酸
本申请包括编码本发明多肽的核苷酸序列或其互补序列。SEQ ID NO：3显示了本发明多肽的编码序列例子。所述“编码序列”包括编码本发明所述多肽(尤其是SEQ ID NO：7)的核酸序列。编码本发明多肽的序列可以与例如SEQ ID NO：3所示的编码区序列相同或者是简并的变异体。如本文所用，“简并的变异体”在本发明中是指相同的氨基酸序列，但核苷酸序列有差别的核苷酸序列。
编码本发明多肽的序列包括：只编码成熟多肽的编码序列；成熟多肽的编码序列和各种附加编码序列；成熟多肽的编码序列(和任选的附加编码序列)以及非编码序列。
本发明还涉及上述多核苷酸的变异体，其编码与本发明有相同的氨基酸序列的片段、类似物、衍生物和变异形式。这些核苷酸变异体包括取代变异体、缺失变异体和插入变异体。如本领域所知的，等位变异体是一个多核苷酸的替换形式，它可能是一个或多个核苷酸的取代、缺失或插入，但不会从实质上改变其编码的蛋白的功能。
本发明也包括编码本发明多肽的核酸序列(如SEQ ID NO：3或其互补序列)的片段。如本文所用，“核酸片段”的长度至少含15个核苷酸，较好是至少30个核苷酸，更好是至少50个核苷酸，最好是至少100个核苷酸以上。核酸片段可用于核酸的扩增技术(如PCR)以确定和/或分离编码本发明多肽的多核苷酸。因此，在某些实施例中，核酸片段的长度在15-30个碱基。可采用现有技术从本发明的核酸序列中挑选出适当的核酸片段，用作引物或探针。
本发明的多肽的编码序列或其片段通常可以用PCR扩增法、重组法或人工合成的方法获得。对于PCR扩增法，可根据本发明所公开的有关核苷酸序列，尤其是开放阅读框序列来设计引物，并用市售的cDNA库或按本领域技术人员已知的常规方法所制备的cDNA库作为模板，扩增而得有关序列。当序列较长时，常常需要进行两次或多次PCR扩增，然后再将各次扩增出的片段按正确次序拼接在一起。
核酸构建体
本发明也涉及包括与指导编码序列在合适宿主细胞中，在与该调控序列相适合的条件下表达的一个或多个调控序列可操作连接的本发明的分离多核苷酸的核酸构建体。术语“可操作连接”指调控序列位于适当的位置从而能控制、指导感兴趣的多核苷酸序列的表达。编码本发明多肽的多核苷酸可以多种方式被操作以保证该多肽的表达。
调控序列可以是合适的启动子序列，为用于表达编码本发明多肽的多核苷酸的宿主细胞识别的核苷酸序列。启动子序列包含接到多肽表达的转录调控序列。启动子可以是在所选择的宿主细胞中显示转录活性的任何核苷酸序列，包括突变的、截短的和杂合启动子，并且可以从编码与该宿主细胞同源或异源的胞外或胞内多肽的基因获得。
用于指导本发明的核酸构建体，特别是在细菌宿主细胞中转录的合适启动子的实例是从噬菌体T7启动子、大肠杆菌lac操纵子、天蓝色链霉菌(Streptomyces coelicolor)琼脂糖酶基因、枯草芽孢杆菌果聚糖蔗糖酶基因、地衣芽孢杆菌α-淀粉酶基因、解淀粉芽孢杆菌α-淀粉酶基因、地衣芽孢杆菌青霉素酶基因等中获得的启动子序列。
用于指导本发明的核酸构建体在丝状真菌宿主细胞正转录的合适启动子的实例是从米曲霉TAKA淀粉酶、米黑根毛霉(Rhizomucor miehei)天冬氨酸蛋白酶、黑曲霉中性α-淀粉酶、黑曲霉酸稳定的α-淀粉酶、黑曲霉或泡盛曲霉糖化酶(glaA)、里氏木霉纤维二糖水解酶I、氏木霉纤维二糖水解酶II、米曲霉碱性蛋白酶、米曲霉磷酸丙糖异构酶、里氏木霉葡聚糖内切酶等基因获得的启动子及其突变、截短和杂合(hybrid)启动子。
在酵母宿主中，有用的启动子可获得自酿酒酵母烯醇酶(ENO-1)、酿酒酵母半乳糖激酶(GAL1)、酿酒酵母乙醇脱氢酶、3-磷酸甘油醛脱氢酶、酿酒酵母磷酸丙糖异构酶、酿酒酵母3-磷酸甘油酸激酶的基因、巴斯德毕赤酵母醇氧化酶基因。用于酵母宿主细胞的其它有用启动子由Romanos et al.，1992，Yeast8:423-488描述。
调控序列也可以是合适的转录终止子序列，为宿主细胞识别以终止转录的序列。终止子序列与编码该多肽的核苷酸序列的3′末端可操作连接。在选择的宿主细胞中有功能的任何终止子都可用于本发明。
用于细菌宿主的优选终止子可以是来自T7噬菌体的终止子。
用于丝状真菌宿主细胞的优选终止子获得自米曲霉TAKA淀粉酶、黑曲霉葡萄糖淀粉酶、构巢曲霉邻氨基苯甲酸合酶、黑曲霉α-葡萄糖苷酶的基因。
用于酵母宿主细胞的优选终止子获得自酿酒酵母烯醇酶、酿酒酵母细胞色素C、酿酒酵母甘油醛-3-磷酸脱氢酶、巴斯德毕赤酵母醇氧化酶基因等。
调控序列也可以是合适的前导序列，对宿主细胞翻译重要的mRNA的非翻译区。签到序列与编码该多肽的核苷酸序列的5′末端可操作连接。在选择的宿主细胞中有功能的任何终止子都可用于本发明。
调控序列也可以是编码与多肽的氨基酸末端连接的氨基酸序列并且指导该编码的多肽进入细胞分泌途径的信号肽编码区。核苷酸序列编码序列的5′端可固有地包含天然连接具有编码分泌多肽的编码区节段的翻译阅读框的信号肽编码区。备选地，编码序列的5′端可包含与该编码区外源的信号肽编码区。当编码序列非天然地包含信号肽编码区时，可能需要外来的信号肽编码区。备选地，外来的信号肽编码区可简单地替换天然的信号肽编码区以增强多肽的分泌。然而，指导表达的多肽进入选择的宿主细胞的分泌途径的任何信号肽编码区，即分泌进入培养基，都可用于本发明。
在某些实施方案中，本发明的核酸构建体为表达框。术语“表达框”是指表达一个基因所需的完整元件，包括启动子、基因编码序列、PolyA加尾信号序列。
载体
本发明也涉及含有本发明多核苷酸或核酸构建体的载体，包括表达载体和克隆载体。表达载体可以是能够方便地经受重组DNA方法并且可导致感兴趣的核苷酸序列表达的任何载体(如质粒或病毒)。克隆载体通常在引入到宿主细胞中后能在宿主细胞中大量繁殖。
载体的选择一般取决于载体与其中被导入该载体的宿主细胞的相容性。该载体可以是线性或闭合的环形质粒。
载体可以是自主复制的载体，即作为染色体外实体存在，其复制不依赖于染色体复制的载体，例如质粒、染色体外元件、微型染色体或人工染色体。载体可包含用于保证自我复制的任何方式。备选地，载体可以是当被导入宿主细胞时，整合到基因组中并且与其已经被整合进入的染色体一起复制的载体。此外，可使用一起包含将被导入宿主细胞基因组的总DNA的单个载体或质粒或两个或多个载体或质粒，或转座子。
本发明的载体优选包含一个或多个容许容易选择转化、转染、转导等细胞的可选择标记。可选择的标记是基因，其产物提供对抗生素或病毒的抗性、对重金属的抗性、原养型至营养缺陷型等。
本发明的载体优选包含容许该载体整合进入宿主细胞基因组或该载体在细胞中独立于基因组自主个复制的元件。
一个以上拷贝的本发明的多核苷酸可被插入宿主细胞以增加该基因产物的产量。多核苷酸拷贝数的增加可通过将至少一个附加拷贝的序列整合进入宿主细胞基因组或通过包括可扩增的选择标记基因和该多核苷酸来获得，其中包含扩增拷贝的选择标记基因并且由此包含附加拷贝多核苷酸的细胞可通过在存在适当的选择剂时培养该细胞来筛选。
本发明的载体优选包含人工合成的一段序列，含有多个限制内切酶识别位点，能为外源DNA提供多种可插入的位置或插入方案。
本发明的表达载体更为优选地选择可用于毕赤酵母中表达的载体。本发明的载体优选商品化的毕赤酵母中使用的载体如pPIC、pPICZ、pAO、pGAP或pGAPZ等一系列的载体。
宿主细胞
本发明也涉及包括被用于重组生产多肽的含有本发明多核苷酸或核酸构建体的重组宿主细胞。包括本发明多核苷酸的载体被导入宿主细胞以使得该载体如早先说明的作为染色体的组成部分或作为染色体外的自我复制载体来维持。宿主细胞的选择很大程度上取决于编码多肽的基因及其来源。
宿主细胞可以是单细胞微生物或非单细胞微生物。单细胞微生物例如革兰氏阳性细菌，包括但不限于芽孢杆菌细胞，例如，嗜碱芽孢杆菌、解淀粉芽孢杆菌、短芽孢杆菌、巨大芽孢杆菌、枯草芽孢杆菌、地衣芽孢杆菌、凝结芽孢杆菌、嗜热脂肪芽孢杆菌和苏云金芽孢杆菌等；或链霉菌细胞，例如钱青紫链霉菌；或革兰氏阴性细菌，例如大肠杆菌和假单胞菌属。在优选的方面，细菌宿主是枯草芽孢杆菌、大肠杆菌、地衣芽孢杆菌、嗜热脂肪芽孢杆菌和大肠杆菌细胞。
宿主细胞也可以是真核生物，例如哺乳动物、昆虫、植物、酵母或真菌细胞。在优选的方面，宿主细胞是真核细胞，如在此使用的“真核”包括子囊菌门(Ascomycota)、担子菌门(Basidiomycota)、壶菌门(Chytridiomycota)、接合菌门(Zygomycota)以及卵菌门等。
在更优选的方面，宿主细胞是子囊菌门的细胞如酵母属(Saccharomyces)、毕赤酵母属(Pichia)、耶氏酵母属(Yarrowia)、假丝酵母属(Candida)以及Komagataella属等。
在最优选的方面，宿主细胞是巴斯德毕赤酵母(Pichia pastoris)、酿酒酵母(Saccharomyces cerevisiae)、解脂耶氏酵母(Yarrowia lipolytica)等。在另外最优选方面，宿主细胞是巴斯德毕赤酵母(Pichia pastoris)细胞。
生产方法
在获得多肽的编码序列后，可采用如下方法生产本发明多肽，该方法包括：(a)在有助于生产多肽的条件下培养含表达该多肽的表达载体的宿主细胞；以及(b)回收该多肽。
本发明的生产方法中，细胞可以利用本领域已知的方法在适于生产多肽的培养基中培养。例如，细胞可通过在实验室或工业发酵罐中进行的摇瓶培养和小规模或大规模的发酵(包括连续的、分批的、分批补料或固态发酵)，在合适的培养基和容许该多肽表达和/或分离的条件下进行培养。培养发生在利用本领域已知的方法包括碳源和氮源和无机盐的合适培养基中。合适的培养基可获得自商业供应者或可根据公开的组合物来制备。如果该多肽分泌进入培养基，该多肽可从培养基直接回收。如果该多肽不分泌进入培养基，它可从细胞裂解物回收。
或者，也可采用本领域已知的化学合成方法来合成本发明的多肽。多肽化学合成方法包括固相合成法和液相合成法，其中以固相合成法常用。固相合成方法包括但不限于Fmoc和tBoc两种常用方法。通常，使用树脂作为不溶性的固相载体，通常从C端(羧基端)向N端(氨基端)逐个将氨基酸连接在肽链上，每个氨基酸连接循环由以下三步反应构成：1)脱保护：被保护的氨基酸必须用一种脱保护溶剂去除氨基的保护基团；2)活化：待连接的氨基酸的羧基被活化剂所活化；和3)偶联：活化的羧基与前一个氨基酸裸露的氨基反应，形成肽键。反复循环直到肽链延伸至所需长度时即可完成。最后用切割液切割肽链和固相载体之间的连接，就可获得所需的氨基酸序列。可以在程序控制的自动化多肽合成仪上进行上述化学合成，这类仪器包括但不限于Protein Technologies公司推出的Tribute双通道多肽合成仪、C S Bio公司的UV Online Monitor系统、Aapptec公司推出的Focus XC三通道合成仪等。
本发明所描述的多肽可利用本领域已知的方法来回收。例如，多肽可通过常规方法，包括但不限于离心、过滤、超滤、萃取、层析、喷雾干燥、冷冻干燥、蒸发或沉淀等从培养基回收。
本发明的多肽可通过本领域已知的多种方法来纯化，包括但不限于色谱法(如离子交换、亲和性、疏水性、色谱聚焦、分子排阻)，电泳法(例如等电聚焦)、差异溶解度(如盐析沉淀)、SDS-PAGE或萃取法以获得基本上纯的多肽。
多肽的性能及用途
本发明的多肽具有磷脂酶C活性，具有提高的比酶活。本发明的多肽可应用于油脂精炼、磷脂改性、饲料改良剂、食品工业和医药工业等多个方面，包括但不限于用于烘烤、用于洗涤剂、改善水溶液或糖浆的过滤性等。在用于脱胶时，本发明的多肽能提高脱胶效率，增加脱胶过程中甘二酯(DAG)的得率。
本发明的多肽可以纯的酶制品的形式提供，也可以组合物的形式提供。组合物可以是粉末组合物，也可以是液体组合物，或糊状组合物。以组合物形式提供时，根据该含酶组合物的不同用途，该组合物可含有不同的辅料。可将本领域已知的辅料添加到本发明的组合物中，这类辅料包括但不限于山梨醇、山梨酸钾、苯甲酸甲酯、苯甲酸乙酯、蔗糖、甘露糖、海藻糖、淀粉、氯化钠、氯化钙等稳定剂或其他物质中的一种或多种。
本发明方法中使用的本发明多肽的量可根据实际情况加以确定。
酶法脱胶
本发明还提供一种酶法脱胶方法，所述方法包括将本发明的多肽加到毛油中进行脱胶的步骤。具体而言，可先将毛油加热至50～70℃，优选50～60℃，然后再加入本发明的多肽，即磷脂酶C。
本发明的磷脂酶C通常以水溶液的形式加入。以毛油重量计，酶的添加量为10～1000ppm，优选为50～500ppm，更优选为100～300ppm。
脱胶条件一般包括：在50～60℃下搅拌1～3小时，然后升温至80～90℃保持1～10分钟。
适用于本发明方法脱胶的毛油包括但不限于大豆油、葵花籽油、花生油、菜籽油、米糠油、玉米油、橄榄油、棕榈油、棕榈仁油、棕榈软脂、卡诺拉油、蓖麻油、椰子油、芫荽油、棉籽油、榛子油、大麻籽油、亚麻籽油、芒果仁油、白芒花油、牛蹄油、红花油、山茶花油、妥尔油、椿油和其他植物油。
下文将以具体实施例的方式阐述本发明。下列实施例中未注明具体条件的实验方法，通常按照常规条件如Sambrook等，《分子克隆：实验室指南》(美国纽约州：冷泉港实验室出版社(Cold Spring Harbor Laboratory Press)，1989)所述的条件，或按照制造厂商所建议的条件进行。对于试剂的用法和用量，除非另有说明，否则按照常规的用法和用量使用。
实验材料
1、实验菌株和质粒
菌株：毕赤酵母SMD1168(Invitrogen，货号C17500)，大肠杆菌DH5a(TAKARA:Catalog#.D9057A)。
2、培养基和溶液
LB液体培养基：0.5％酵母提取物，1％胰化蛋白胨，1％NaCl，pH7.0。
LB固体培养基：在LB液体培养基中加入琼脂浓度1.5％。
YPD液体培养基：1％酵母提取物，2％蛋白胨，2％葡萄糖。
YPD固体培养基：在LB液体培养基中加入琼脂浓度2％。
MGYS固体培养基：1.34％酵母氮源碱(YNB)含硫酸铵不含氨基酸，1％甘油，1M山梨醇，4×10-5％D-生物素，2％琼脂。
BMM-大豆磷脂筛选培养基：1.34％酵母氮源碱(YNB)含硫酸铵不含氨基酸，4×10-5％D-生物素，0.5％甲醇(灭菌后加入)，2％大豆磷脂乳化液，0.1M柠檬酸-柠檬酸钠缓冲液(pH6.6)，2％琼脂，添加10uM的ZnSO4·7H2O。
2％大豆磷脂乳化液：2g大豆磷脂，100ml H2O，用高速匀浆机8000rpm匀浆1min。
BMGY液体培养基：1％酵母提取物，2％蛋白胨，1.34％酵母氮源碱(YNB)含硫酸铵不含氨基酸，1％甘油，4×10-5％D-生物素，0.1M磷酸二氢钾-磷酸氢二钾缓冲液(pH6.0)。
BMMY液体培养基：1％酵母提取物，2％蛋白胨，1.34％酵母氮源碱(YNB)含硫酸铵不含氨基酸，0.3％ZnSO4·7H2O，0.5％甲醇(灭菌后加入)，4×10-5％D-生物素(灭菌后加入)，0.1M柠檬酸-柠檬酸钠缓冲液(pH6.6)。
3、酶活测定方法pNPPC法
磷脂酶活力测定标准曲线的绘制：
称取0.01391g对硝基苯酚，溶于50ml无菌水中配成2mmol/L工作液。各种试剂的加量见表制作标准曲线时的反应体积和反应条件与试验中测定样品酶活的条件相一致。
以上各种溶液混合后，在37℃处理15分钟，加500ul 0.5N的NaOH，410nm测定吸光度。所得标准曲线如图3所示。
4、反应缓冲液
0.1M硼酸-硼酸钠缓冲液(pH 7.6)，20mM pNPPC。
5、酶活计算
取600ul上述反应缓冲液，加入25ul待测酶液，37℃反应15min，加500ul 0.5N的NaOH终止反应，410nm测定吸光度。
样品酶活(U/ml)＝A(410nm吸光度)×0.1935×稀释倍数×10/15。
改良型Bradford法蛋白浓度测定试剂盒购自上海生工生物工程有限公司；PCR酶为HS DNA Polymerase，购自宝生物工程(大连)有限公司；T4DNA连接酶购自富酶泰斯有限公司。
实施例1：饱和突变体文库构建及筛选
以pmAO-PLC-N63DN131SN134D-Y56H载体(见CN 201680072289.5，PLC-N63DN131SN134D-Y56H的DNA序列如SEQ ID NO:1所示，其编码的氨基酸序列如SEQ ID NO:2所示)为模板，委托苏州泓迅生物科技股份有限公司构建第6位，第8位，第10位，第104位，第205位氨基酸进行随机饱和突变文库。将质粒文库转化入大肠杆菌DH5α菌株，将所有大肠杆菌克隆洗至LB液体培养基中(含100μg/ml氨苄青霉素)，37℃培养4h。抽提质粒，用SalI进行线性化，回收约8.5kb的片段。取500ng载体，用电转化法将载体转化至毕赤酵母SMD1168菌株的感受态细胞中。将转化物接种于MGYS平板上，30℃培养3天，得到PLC-N63DN131SN134D-Y56H的毕赤酵母突变体文库。挑取平板上的单克隆，至BMM-大豆磷脂筛选平板上。选取白色沉淀圈相对较大的克隆之一，编号31#。
实施例2：31#突变体序列分析
将31#菌株接种于3ml YPD液体培养基中，30℃培养过夜，抽提基因组DNA。以31#菌株的基因组DNA为模板，使用HS DNA聚合酶和引物对AOX1-5/AOX1-3进行PCR扩增，得到31#菌株中PLC的DNA序列。将得到的序列送往上海生工生物工程公司，用引物对AOX1-5/AOX1-3进行测序：
AOX1-5：CGACTGGTTCCAATTGACAACG(SEQ ID NO:5)；
AOX1-3：GGCAAATGGCATTCTGACATCCTC(SEQ ID NO:6)。
31#的PLC的DNA测序结果如SEQ ID NO:3所述，根据测序结果，31#的PLC的DNA序列有5个碱基发生了突变，其编码氨基酸的序列如SEQ ID NO:4所述，其氨基酸序列的第6位、第8位、第10位和第104位氨基酸分别由赖氨酸、赖氨酸、甘氨酸和赖氨酸突变为脯氨酸、缬氨酸、丝氨酸和丝氨酸。
实施例3：31#突变体摇瓶发酵酶活
取31#菌株及母本菌株(即转入了pmAO-PLC-N63DN131SN134D-Y56H载体的SMD1168)，先在液体YPD中活化，然后接种于BMGY培养基中，在30℃下，220rpm振荡培养过夜。将培养物转至BMMY培养基中，初始OD600为6。
首先，用2％甲醇进行诱导，在24h和32h后各补加1％甲醇，48h和56h后各补加1％甲醇，72h取样。将获得的样品用截留分子量为10kDa的超滤管进行超滤脱盐浓缩40倍。将处理后的样品加入缓冲液中(20mM柠檬酸-柠檬酸钠缓冲液(pH6.6)，10uM ZnSO4)。
取0.5μl发酵液浓缩液至600ul pNPPC反应缓冲液中，37℃反应15min，加500ul0.5N的NaOH终止反应，410nm测定吸光度。根据标准曲线，计算得到各个发酵液样品的PLC活力。用Bradford试剂测定摇瓶发酵液的蛋白浓度，从而得出比酶活。结果如图1所示，31#突变体发酵液样品的比酶活较母本菌株发酵液样品的比酶活有1.88倍的提高。
实施例4：31#脱胶小试
取大豆毛油100g，加热至55℃，分别加入50ppm和100ppm实施例3获得的31#突变体发酵液样品和母本菌株发酵液样品，使得体系中的水相为3％，用高速剪切机高速剪切(10000r/min)1min，在55℃下搅拌(750r/min)反应2h，升温至85℃，维持5min，样品12000rpm离心10min，取约10g上层油样，用HPLC检测其DAG含量。31#突变体发酵液样品和母本菌株发酵液样品相对于毛油的DAG增量如图2所示，31#突变体发酵液样品50ppm酶用量时的DAG增量与母本菌株发酵液样品100ppm时的DAG增量相同。因此31#突变体发酵液样品脱胶时的酶用量可以较母本菌株发酵液样品减少1倍。
序列表
<110> 丰益（上海）生物技术研发中心有限公司
<120> 一种高酶活的磷脂酶C突变体
<130> 188686
<160> 7
<170> SIPOSequenceListing 1.0
<210> 1
<211> 738
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 1
tggtcagctg aggacaagca taaggaaggt gtgaatagtc acttatggat cgtgaaccgt 60
gccattgata taatgtctag gaatacaact ctggttaagc aagatagagt tgctcaattg 120
aatgaatggc gtacagagct agagaatggc atctacgctg ctgatcatga aaacccctat 180
tacgatgaca gtaccttcgc ttctcacttt tacgatccag acaacggaaa gacatatatc 240
ccattcgcca agcaagctaa ggagactgga gctaagtact tcaagttggc tggagagtca 300
tacaagaata aagacatgaa gcaggccttc ttttatcttg ggttgtcatt gcattatttg 360
ggcgatgtca accaacctat gcatgccgca tcctttacgg acctgtccta tccacagggt 420
tttcactcca agtacgagaa ctttgtcgat actattaaag acaactacaa agttaccgat 480
gggaacggat attggaattg gaaaggcacc aaccctgaag aatggattca cggtgcagca 540
gtagttgcaa aacaggacta ctctggaatt gtcaatgaca ataccaaaga ttggtttgtg 600
aaagccgcag tctcccagga atatgcagat aaatggagag ctgaagttac acctatgact 660
ggtaaacgac taatggatgc ccaaagagtt actgctggtt acattcaatt atggttcgac 720
acttacggtg acaggtaa 738
<210> 2
<211> 245
<212> PRT
<213> 人工序列(Artificial Sequence)
<400> 2
Trp Ser Ala Glu Asp Lys His Lys Glu Gly Val Asn Ser His Leu Trp
1 5 10 15
Ile Val Asn Arg Ala Ile Asp Ile Met Ser Arg Asn Thr Thr Leu Val
20 25 30
Lys Gln Asp Arg Val Ala Gln Leu Asn Glu Trp Arg Thr Glu Leu Glu
35 40 45
Asn Gly Ile Tyr Ala Ala Asp His Glu Asn Pro Tyr Tyr Asp Asp Ser
50 55 60
Thr Phe Ala Ser His Phe Tyr Asp Pro Asp Asn Gly Lys Thr Tyr Ile
65 70 75 80
Pro Phe Ala Lys Gln Ala Lys Glu Thr Gly Ala Lys Tyr Phe Lys Leu
85 90 95
Ala Gly Glu Ser Tyr Lys Asn Lys Asp Met Lys Gln Ala Phe Phe Tyr
100 105 110
Leu Gly Leu Ser Leu His Tyr Leu Gly Asp Val Asn Gln Pro Met His
115 120 125
Ala Ala Ser Phe Thr Asp Leu Ser Tyr Pro Gln Gly Phe His Ser Lys
130 135 140
Tyr Glu Asn Phe Val Asp Thr Ile Lys Asp Asn Tyr Lys Val Thr Asp
145 150 155 160
Gly Asn Gly Tyr Trp Asn Trp Lys Gly Thr Asn Pro Glu Glu Trp Ile
165 170 175
His Gly Ala Ala Val Val Ala Lys Gln Asp Tyr Ser Gly Ile Val Asn
180 185 190
Asp Asn Thr Lys Asp Trp Phe Val Lys Ala Ala Val Ser Gln Glu Tyr
195 200 205
Ala Asp Lys Trp Arg Ala Glu Val Thr Pro Met Thr Gly Lys Arg Leu
210 215 220
Met Asp Ala Gln Arg Val Thr Ala Gly Tyr Ile Gln Leu Trp Phe Asp
225 230 235 240
Thr Tyr Gly Asp Arg
245
<210> 3
<211> 738
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 3
tggtcagctg aggacccgca tgttgaatcg gtgaatagtc acttatggat cgtgaaccgt 60
gccattgata taatgtctag gaatacaact ctggttaagc aagatagagt tgctcaattg 120
aatgaatggc gtacagagct agagaatggc atctacgctg ctgatcatga aaacccctat 180
tacgatgaca gtaccttcgc ttctcacttt tacgatccag acaacggaaa gacatatatc 240
ccattcgcca agcaagctaa ggagactgga gctaagtact tcaagttggc tggagagtca 300
tacaagaatt ctgacatgaa gcaggccttc ttttatcttg ggttgtcatt gcattatttg 360
ggcgatgtca accaacctat gcatgccgca tcctttacgg acctgtccta tccacagggt 420
tttcactcca agtacgagaa ctttgtcgat actattaaag acaactacaa agttaccgat 480
gggaacggat attggaattg gaaaggcacc aaccctgaag aatggattca cggtgcagca 540
gtagttgcaa aacaggacta ctctggaatt gtcaatgaca ataccaaaga ttggtttgtg 600
aaagccgcag tctcccagga atatgcagat aaatggagag ctgaagttac acctatgact 660
ggtaaacgac taatggatgc ccaaagagtt actgctggtt acattcaatt atggttcgac 720
acttacggtg acaggtaa 738
<210> 4
<211> 245
<212> PRT
<213> 人工序列(Artificial Sequence)
<400> 4
Trp Ser Ala Glu Asp Pro His Val Glu Ser Val Asn Ser His Leu Trp
1 5 10 15
Ile Val Asn Arg Ala Ile Asp Ile Met Ser Arg Asn Thr Thr Leu Val
20 25 30
Lys Gln Asp Arg Val Ala Gln Leu Asn Glu Trp Arg Thr Glu Leu Glu
35 40 45
Asn Gly Ile Tyr Ala Ala Asp Trp Glu Asn Pro Tyr Tyr Asp Asp Ser
50 55 60
Thr Phe Ala Ser His Phe Tyr Asp Pro Asp Asn Gly Lys Thr Tyr Ile
65 70 75 80
Pro Phe Ala Lys Gln Ala Lys Glu Thr Gly Ala Lys Tyr Phe Lys Leu
85 90 95
Ala Gly Glu Ser Tyr Lys Asn Ser Asp Met Lys Gln Ala Phe Phe Tyr
100 105 110
Leu Gly Leu Ser Leu His Tyr Leu Gly Asp Val Asn Gln Pro Met His
115 120 125
Ala Ala Ser Phe Thr Asp Leu Ser Tyr Pro Gln Gly Phe His Ser Lys
130 135 140
Tyr Glu Asn Phe Val Asp Thr Ile Lys Asp Asn Tyr Lys Val Thr Asp
145 150 155 160
Gly Asn Gly Tyr Trp Asn Trp Lys Gly Thr Asn Pro Glu Glu Trp Ile
165 170 175
His Gly Ala Ala Val Val Ala Lys Gln Asp Tyr Ser Gly Ile Val Asn
180 185 190
Asp Asn Thr Lys Asp Trp Phe Val Lys Ala Ala Val Ser Gln Glu Tyr
195 200 205
Ala Asp Lys Trp Arg Ala Glu Val Thr Pro Met Thr Gly Lys Arg Leu
210 215 220
Met Asp Ala Gln Arg Val Thr Ala Gly Tyr Ile Gln Leu Trp Phe Asp
225 230 235 240
Thr Tyr Gly Asp Arg
245
<210> 5
<211> 22
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 5
cgactggttc caattgacaa cg 22
<210> 6
<211> 24
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 6
ggcaaatggc attctgacat cctc 24
<210> 7
<211> 245
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<221> MUTAGEN
<222> (6)..(6)
<223> Xaa为丙氨酸、缬氨酸、亮氨酸、异亮氨酸、脯氨酸、苯丙氨酸、甲硫氨酸或色氨酸
<220>
<221> MUTAGEN
<222> (8)..(8)
<223> Xaa为丙氨酸、缬氨酸、亮氨酸、异亮氨酸、脯氨酸、苯丙氨酸、甲硫氨酸或色氨酸
<220>
<221> MUTAGEN
<222> (10)..(10)
<223> Xaa为甘氨酸、天冬酰胺、谷氨酰胺、丝氨酸、苏氨酸、酪氨酸或半胱氨酸
<220>
<221> MUTAGEN
<222> (104)..(104)
<223> Xaa为甘氨酸、天冬酰胺、谷氨酰胺、丝氨酸、苏氨酸、酪氨酸或半胱氨酸
<220>
<221> UNSURE
<222> (6)..(6)
<223> The 'Xaa' at location 6 stands for Gln, Arg, Pro, or Leu.
<220>
<221> UNSURE
<222> (8)..(8)
<223> The 'Xaa' at location 8 stands for Gln, Arg, Pro, or Leu.
<220>
<221> UNSURE
<222> (10)..(10)
<223> The 'Xaa' at location 10 stands for Gln, Arg, Pro, or Leu.
<220>
<221> UNSURE
<222> (104)..(104)
<223> The 'Xaa' at location 104 stands for Gln, Arg, Pro, or Leu.
<400> 7
Trp Ser Ala Glu Asp Xaa His Xaa Glu Xaa Val Asn Ser His Leu Trp
1 5 10 15
Ile Val Asn Arg Ala Ile Asp Ile Met Ser Arg Asn Thr Thr Leu Val
20 25 30
Lys Gln Asp Arg Val Ala Gln Leu Asn Glu Trp Arg Thr Glu Leu Glu
35 40 45
Asn Gly Ile Tyr Ala Ala Asp Trp Glu Asn Pro Tyr Tyr Asp Asp Ser
50 55 60
Thr Phe Ala Ser His Phe Tyr Asp Pro Asp Asn Gly Lys Thr Tyr Ile
65 70 75 80
Pro Phe Ala Lys Gln Ala Lys Glu Thr Gly Ala Lys Tyr Phe Lys Leu
85 90 95
Ala Gly Glu Ser Tyr Lys Asn Xaa Asp Met Lys Gln Ala Phe Phe Tyr
100 105 110
Leu Gly Leu Ser Leu His Tyr Leu Gly Asp Val Asn Gln Pro Met His
115 120 125
Ala Ala Ser Phe Thr Asp Leu Ser Tyr Pro Gln Gly Phe His Ser Lys
130 135 140
Tyr Glu Asn Phe Val Asp Thr Ile Lys Asp Asn Tyr Lys Val Thr Asp
145 150 155 160
Gly Asn Gly Tyr Trp Asn Trp Lys Gly Thr Asn Pro Glu Glu Trp Ile
165 170 175
His Gly Ala Ala Val Val Ala Lys Gln Asp Tyr Ser Gly Ile Val Asn
180 185 190
Asp Asn Thr Lys Asp Trp Phe Val Lys Ala Ala Val Ser Gln Glu Tyr
195 200 205
Ala Asp Lys Trp Arg Ala Glu Val Thr Pro Met Thr Gly Lys Arg Leu
210 215 220
Met Asp Ala Gln Arg Val Thr Ala Gly Tyr Ile Gln Leu Trp Phe Asp
225 230 235 240
Thr Tyr Gly Asp Arg
245
Claims (14)
1.一种分离的多肽，其特征在于，所述多肽的氨基酸序列如SEQ ID NO:4所示。
2.一种多核苷酸，其多核苷酸序列选自：
（1）编码权利要求1所述多肽的多核苷酸序列；和
（2）与（1）所述多核苷酸互补的序列。
3.如权利要求2所述的多核苷酸，其特征在于，所述多核苷酸序列如SEQ ID NO:3所示。
4.一种核酸构建体，其特征在于，该核酸构建体包含权利要求2或3所述的多核苷酸和一条或多条与权利要求2或3所述的多核苷酸操作性连接的调控序列。
5.如权利要求4所述的核酸构建体，其特征在于，所述核酸构建体为载体。
6.如权利要求5所述的核酸构建体，其特征在于，所述载体为表达载体或克隆载体。
7.一种遗传工程化的宿主细胞，其特征在于，所述宿主细胞含有权利要求2或3所述的多核苷酸或权利要求4-6中任一项所述的核酸构建体。
8.一种组合物，其特征在于，所述组合物含有权利要求1所述的多肽和辅料。
9.如权利要求8所述的组合物，其特征在于，所述辅料为吸附材料，所述吸附材料选自活性炭、氧化铝、硅藻土、多孔陶瓷和多孔玻璃。
10.权利要求1所述的多肽、权利要求2或3所述的多核苷酸、权利要求4-6中任一项所述的核酸构建体、权利要求7所述的宿主细胞或权利要求8-9中任一项所述的组合物在酶法脱胶中的应用。
11.一种酶法脱胶方法，其特征在于，所述方法包括使用权利要求1所述的多肽进行脱胶，其中，所述方法包括将权利要求1所述的多肽与50-70℃的毛油接触的步骤。
12.如权利要求11所述的方法，其特征在于，所述方法包括以下特征中的一项或多项：
（1）以毛油重量计，所述多肽的添加量为10～1000ppm；
（2）所述脱胶包括：在50～60℃下搅拌1～3小时，然后升温至80～90℃保持1～10分钟；和
（3）所述毛油选自：大豆油、葵花籽油、花生油、菜籽油、米糠油、玉米油、橄榄油、棕榈油、棕榈仁油、棕榈软脂、卡诺拉油、蓖麻油、椰子油、芫荽油、棉籽油、榛子油、大麻籽油、亚麻籽油、芒果仁油、白芒花油、牛蹄油、红花油、山茶花油、妥尔油和椿油。
13.如权利要求12所述的方法，其特征在于，（1）中，以毛油重量计，所述多肽的添加量为50～500ppm。
14.如权利要求12所述的方法，其特征在于，（1）中，以毛油重量计，所述多肽的添加量为100～300ppm。
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811620055.7A CN111378633B (zh) | 2018-12-28 | 2018-12-28 | 一种高酶活的磷脂酶c突变体 |
| PCT/CN2019/128970 WO2020135657A1 (zh) | 2018-12-28 | 2019-12-27 | 一种高酶活的磷脂酶c突变体 |
| US17/419,091 US20220064611A1 (en) | 2018-12-28 | 2019-12-27 | Phospholipase C Mutant With High Enzyme Activity |
| EP19902338.3A EP3904509A4 (en) | 2018-12-28 | 2019-12-27 | PHOSPHOLIPASE-C MUTANT WITH HIGH ENZYME ACTIVITY |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811620055.7A CN111378633B (zh) | 2018-12-28 | 2018-12-28 | 一种高酶活的磷脂酶c突变体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111378633A CN111378633A (zh) | 2020-07-07 |
| CN111378633B true CN111378633B (zh) | 2024-03-29 |
Family
ID=71125726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811620055.7A Active CN111378633B (zh) | 2018-12-28 | 2018-12-28 | 一种高酶活的磷脂酶c突变体 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220064611A1 (zh) |
| EP (1) | EP3904509A4 (zh) |
| CN (1) | CN111378633B (zh) |
| WO (1) | WO2020135657A1 (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR128262A1 (es) | 2022-01-14 | 2024-04-10 | Keclon S A | Enzima fosfolipasa c mutada y procedimiento de desgomado enzimático |
| WO2023225459A2 (en) | 2022-05-14 | 2023-11-23 | Novozymes A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106459934A (zh) * | 2014-05-15 | 2017-02-22 | 诺维信公司 | 包括具有磷脂酶c活性的多肽的组合物及其应用 |
| CN106884009A (zh) * | 2015-12-16 | 2017-06-23 | 丰益(上海)生物技术研发中心有限公司 | 高效的不依赖锌离子的磷脂酶c突变体 |
| CN108118039A (zh) * | 2016-11-28 | 2018-06-05 | 丰益(上海)生物技术研发中心有限公司 | 一种磷脂酶c突变体 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA111708C2 (uk) * | 2009-10-16 | 2016-06-10 | Бандж Ойлз, Інк. | Спосіб рафінування олії |
| CN104630174B (zh) * | 2013-11-07 | 2019-09-27 | 丰益(上海)生物技术研发中心有限公司 | 磷脂酶c突变体及其用途 |
| US10351795B2 (en) * | 2014-03-19 | 2019-07-16 | Novozymes A/S | Polypeptides having phospholipase C activity and polynucleotides encoding same |
| CN106459935A (zh) * | 2014-03-27 | 2017-02-22 | 诺维信公司 | 具有磷脂酶c活性的多肽和编码它们的多核苷酸 |
| CN108384768A (zh) * | 2018-02-28 | 2018-08-10 | 江苏中酶生物科技有限公司 | 一种磷脂酶c的突变体及其应用 |
-
2018
- 2018-12-28 CN CN201811620055.7A patent/CN111378633B/zh active Active
-
2019
- 2019-12-27 US US17/419,091 patent/US20220064611A1/en active Pending
- 2019-12-27 EP EP19902338.3A patent/EP3904509A4/en active Pending
- 2019-12-27 WO PCT/CN2019/128970 patent/WO2020135657A1/zh unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106459934A (zh) * | 2014-05-15 | 2017-02-22 | 诺维信公司 | 包括具有磷脂酶c活性的多肽的组合物及其应用 |
| CN106884009A (zh) * | 2015-12-16 | 2017-06-23 | 丰益(上海)生物技术研发中心有限公司 | 高效的不依赖锌离子的磷脂酶c突变体 |
| CN108118039A (zh) * | 2016-11-28 | 2018-06-05 | 丰益(上海)生物技术研发中心有限公司 | 一种磷脂酶c突变体 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111378633A (zh) | 2020-07-07 |
| EP3904509A1 (en) | 2021-11-03 |
| EP3904509A4 (en) | 2022-10-19 |
| WO2020135657A1 (zh) | 2020-07-02 |
| US20220064611A1 (en) | 2022-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108431218B (zh) | 高效的不依赖锌离子的磷脂酶c突变体 | |
| CA2158357C (en) | Purification and molecular cloning of eg iii cellulase | |
| CN108239627B (zh) | 活性提高的脂肪酶及其应用 | |
| CA2204257C (en) | Tripeptidyl aminopeptidase | |
| WO2015067161A1 (zh) | 磷脂酶c突变体及其用途 | |
| CN108118039B (zh) | 一种磷脂酶c突变体 | |
| CN111378633B (zh) | 一种高酶活的磷脂酶c突变体 | |
| CN108251400B (zh) | 脂肪酶及其应用 | |
| CN108239648B (zh) | 高效表达米黑根毛霉脂肪酶的方法 | |
| CN108239626B (zh) | 一种高酯化活力的脂肪酶突变体 | |
| JPH0662869A (ja) | 超好熱性α−アミラーゼ遺伝子 | |
| CN113755468A (zh) | 一种对胰蛋白酶抗性提高的玉米赤霉烯酮水解酶 | |
| CN108220267B (zh) | 磷脂酶及其应用 | |
| CN106635941B (zh) | 一种来源于Aquifex aeolicus菌株的嗜热酯酶及其功能验证 | |
| RU2818353C2 (ru) | Мутант фосфолипазы С с высокой ферментативной активностью | |
| CN106632683B (zh) | 具有pNPPC水解酶活性的多肽，其编码基因、制备方法及应用 | |
| CN106701714B (zh) | 磷脂酶、编码基因、制备方法及其应用 | |
| CN111378634B (zh) | 具有磷脂酶c活性的多肽及其用途 | |
| CN106479996B (zh) | 一种新型的淀粉酶 | |
| CN113913414B (zh) | 高稳定性和高催化效率的双碱基酶Kex2突变体 | |
| CN110452892B (zh) | 一种宏基因来源的脂肪酶、编码基因、载体、工程菌及在叶黄素制备中的应用 | |
| CN111197041B (zh) | 制备青鳉鱼肠激酶活性亚基的方法、其产物和用途 | |
| CN108103045B (zh) | 脂肪酶及其应用 | |
| KR101945925B1 (ko) | 이소부틸렌 합성용 단백질 및 이를 이용한 이소부틸렌 제조방법 | |
| KR20230057844A (ko) | PETase의 세포외 분비용 재조합 균주 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |